Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Revenue (2023 - 2025)

Historic Revenue for Praxis Precision Medicines (PRAX) over the last 2 years, with Q4 2024 value amounting to $7.5 million.

  • Praxis Precision Medicines' Revenue rose 134912.62% to $7.5 million in Q4 2024 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year increase of 36498.44%. This contributed to the annual value of $8.6 million for FY2024, which is 24953.0% up from last year.
  • According to the latest figures from Q4 2024, Praxis Precision Medicines' Revenue is $7.5 million, which was up 134912.62% from $302000.0 recorded in Q3 2024.
  • Praxis Precision Medicines' 5-year Revenue high stood at $7.5 million for Q4 2024, and its period low was $302000.0 during Q3 2024.